FIELD: pharmacology.
SUBSTANCE: medicament is presented comprising active substances, excipients and a consistently-forming base, characterized by comprising fluconazole, metronidazole, alpha- or beta- or gamma-recombinant interferon as active substances, disodium edetate and boric acid as adjuvants, and substances selected from the group: macrogol 400, macrogol 1500, macrogol 4000, vitepsol, glycerin, cocoa butter, paraffin, lanolin, vaseline, acetylphthalyl, GL type solid fat as a consistently forming base, wherein the drug components are in a specific ratio in g per 1 g of the agent.
EFFECT: high therapeutic effect ensures rapid substances entry into the blood.
1 cl
Title | Year | Author | Number |
---|---|---|---|
CO-DRUG EXHIBITING ANTIMYCOTIC, ANTIVIRAL, ANTIMICROBIAL, ANTI-INFLAMMATORY, IMMUNOMODULATING AND BACTERICIDAL ACTION FOR EXTERNAL OR LOCAL APPLICATION | 2010 |
|
RU2431497C1 |
DRUG HERPFERON-2 POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANALGESIC ACTION FOR LOCAL AND EXTERNAL APPLICATION | 2012 |
|
RU2488405C1 |
GEL PHARMACEUTICAL COMPOSITION FOR BLEPHARITIS TREATMENT | 2016 |
|
RU2633054C1 |
ANTIVIRAL AGENT IN LIQUID FORM AND METHOD FOR ITS PREPARATION | 2021 |
|
RU2768656C1 |
PHARMACEUTICAL COMPOSITION DENTOFERON IN FORM OF GEL FOR PREVENTING AND TREATING PERIODONTAL DISEASES | 2012 |
|
RU2490006C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECOSIS, POSSESSING ANTIPARASITIC, ANTIBACTERIAL, ANTIVIRAL, IMMUNOMODULATORY ACTION | 2013 |
|
RU2538710C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF CAPSULE POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, ANTIMICROBIAL AND IMMUNOMODULATORY ACTION | 2012 |
|
RU2482872C1 |
THERAPEUTIC AGENT IN FORM OF GEL FOR TREATING HERPETIC INFECTION MANIFESTATIONS IN PATIENTS WITH BURNS AND COLD INJURIES | 2013 |
|
RU2544163C1 |
EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
CYTOKINE-CONTAINING MEDICATION, POSSESSING ANTIVIRAL, ANTIMICROBIAL, IMMUNOMODULATING AND ANTI-INFLAMMATORY ACTION FOR PREVENTION AND TREATMENT OF INFECTION DISEASES | 2013 |
|
RU2554495C2 |
Authors
Dates
2017-10-11—Published
2016-10-19—Filed